IL155814A0 - Treatment of sexual dysfunction using bombesin antagonist - Google Patents
Treatment of sexual dysfunction using bombesin antagonistInfo
- Publication number
- IL155814A0 IL155814A0 IL15581400A IL15581400A IL155814A0 IL 155814 A0 IL155814 A0 IL 155814A0 IL 15581400 A IL15581400 A IL 15581400A IL 15581400 A IL15581400 A IL 15581400A IL 155814 A0 IL155814 A0 IL 155814A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- sexual dysfunction
- bombesin antagonist
- bombesin
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2000/004380 WO2002040022A1 (en) | 2000-11-17 | 2000-11-17 | Treatment of sexual dysfunction using bombesin antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155814A0 true IL155814A0 (en) | 2003-12-23 |
Family
ID=9886325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15581400A IL155814A0 (en) | 2000-11-17 | 2000-11-17 | Treatment of sexual dysfunction using bombesin antagonist |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1333829A1 (xx) |
| JP (1) | JP2004525864A (xx) |
| KR (1) | KR20040062416A (xx) |
| CN (1) | CN1479618A (xx) |
| AU (1) | AU2001214046A1 (xx) |
| BR (1) | BR0017374A (xx) |
| CA (1) | CA2426521A1 (xx) |
| HU (1) | HUP0303500A2 (xx) |
| IL (1) | IL155814A0 (xx) |
| MX (1) | MXPA03003481A (xx) |
| PL (1) | PL366002A1 (xx) |
| WO (1) | WO2002040022A1 (xx) |
| ZA (1) | ZA200303250B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10123163A1 (de) | 2001-05-09 | 2003-01-16 | Gruenenthal Gmbh | Substituierte Cyclohexan-1,4-diaminderivate |
| US7244743B2 (en) | 2002-06-05 | 2007-07-17 | Solvay Pharmaceuticals Gmbh | Non-peptidic BRS-3 agonists |
| CN117665174B (zh) * | 2024-02-01 | 2024-04-23 | 巴中市产品质量检验检测中心 | 一种检测pde5和ssri的方法及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5369094A (en) * | 1990-11-29 | 1994-11-29 | The Administrators Of The Tulane Educational Fund | Polypeptide bombesin antagonists |
| US5650395A (en) * | 1995-03-13 | 1997-07-22 | Hurel; Steven | Treatment of pulmonary hypertension |
| US6194437B1 (en) * | 1996-08-22 | 2001-02-27 | Warner-Lambert Company | Non-peptide bombesin receptor antagonists |
| AU2180600A (en) * | 1998-12-18 | 2000-07-12 | Warner-Lambert Company | Non-peptide nk1 receptors antagonists |
| WO2000067708A2 (en) * | 1999-05-07 | 2000-11-16 | Board Of Regents, The University Of Texas System | Oral steroidal hormone compositions and methods of use |
| EP1057829B1 (en) * | 1999-06-04 | 2002-11-20 | The Jordanian Pharmaceutical Manufacturing and Medical Equipment Co.Ltd. | Novel compounds and pharmaceutical compositions containing the same |
-
2000
- 2000-11-17 MX MXPA03003481A patent/MXPA03003481A/es unknown
- 2000-11-17 KR KR10-2003-7006676A patent/KR20040062416A/ko active IP Right Grant
- 2000-11-17 IL IL15581400A patent/IL155814A0/xx unknown
- 2000-11-17 PL PL00366002A patent/PL366002A1/xx not_active Application Discontinuation
- 2000-11-17 JP JP2002542395A patent/JP2004525864A/ja active Pending
- 2000-11-17 CA CA002426521A patent/CA2426521A1/en not_active Abandoned
- 2000-11-17 CN CNA008201218A patent/CN1479618A/zh active Pending
- 2000-11-17 AU AU2001214046A patent/AU2001214046A1/en not_active Abandoned
- 2000-11-17 BR BR0017374-6A patent/BR0017374A/pt not_active IP Right Cessation
- 2000-11-17 HU HU0303500A patent/HUP0303500A2/hu unknown
- 2000-11-17 EP EP00976165A patent/EP1333829A1/en not_active Withdrawn
- 2000-11-17 WO PCT/GB2000/004380 patent/WO2002040022A1/en not_active Application Discontinuation
-
2003
- 2003-04-25 ZA ZA200303250A patent/ZA200303250B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1479618A (zh) | 2004-03-03 |
| AU2001214046A1 (en) | 2002-05-27 |
| HUP0303500A2 (hu) | 2004-01-28 |
| EP1333829A1 (en) | 2003-08-13 |
| PL366002A1 (en) | 2005-01-24 |
| MXPA03003481A (es) | 2004-09-10 |
| ZA200303250B (en) | 2004-04-26 |
| JP2004525864A (ja) | 2004-08-26 |
| WO2002040022A1 (en) | 2002-05-23 |
| CA2426521A1 (en) | 2002-05-23 |
| KR20040062416A (ko) | 2004-07-07 |
| BR0017374A (pt) | 2003-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL153492A0 (en) | Treatment of male sexual dysfunction | |
| HK1040901A1 (en) | Treatment of female sexual dysfunction | |
| AU5040101A (en) | Improved treatment of neovascularization | |
| GB0225908D0 (en) | Treatment of female sexual dysfunction | |
| IL154642A0 (en) | Treatment of urinary dysfunction | |
| PL362980A1 (en) | Treatment of sexual dysfunction | |
| IL162455A0 (en) | Compounds for the treatment of sexual dysfunction | |
| IL155775A0 (en) | Treatment of male sexual dysfunction | |
| AU2002246924A8 (en) | Treatment of erectile dysfunction with rho-kinase inhibitors | |
| IL154215A0 (en) | Medicine for fighting against sexual dysfunction | |
| IL155814A0 (en) | Treatment of sexual dysfunction using bombesin antagonist | |
| AU8906201A (en) | Methods and compositions for the treatment and prevention of sexual dysfunction | |
| GB2386555B (en) | Treatment of female sexual dysfunction | |
| IL166273A0 (en) | Methods of treatment of male erectile dysfunction | |
| GB0011926D0 (en) | Treatment of sexual dysfunction | |
| GB0030647D0 (en) | Treatment of male sexual dysfunction | |
| GB0109910D0 (en) | Treatment of sexual dysfunction | |
| GB0111037D0 (en) | Treatment of sexual dysfunction | |
| GB0126904D0 (en) | Treatment of sexual dysfunction | |
| GB0108730D0 (en) | Treatment of male sexual dysfunction | |
| GB0120679D0 (en) | Treatment of male sexual dysfunction | |
| GB0108483D0 (en) | Treatment of male sexual dysfunction | |
| GB0106167D0 (en) | Treatment of male sexual dysfunction | |
| GB0127006D0 (en) | Treatment of moccasion seam | |
| GB0202282D0 (en) | Treatment of male sexual dysfunction |